Literature DB >> 24442765

Galactose treatment in focal and segmental glomerulosclerosis.

Om P Mishra1, Arun K Singh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24442765     DOI： 10.1007/s00467-013-2731-1

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  3 in total

1.  Partial remission of resistant nephrotic syndrome after oral galactose therapy.

Authors:  Matjaž Kopač; Anamarija Meglič; Rina R Rus
Journal:  Ther Apher Dial       Date:  2011-06       Impact factor: 1.762

2.  Effect of galactose on glomerular permeability and proteinuria in steroid-resistant nephrotic syndrome.

Authors:  Kristen Sgambat; Mindy Banks; Asha Moudgil
Journal:  Pediatr Nephrol       Date:  2013-06-22       Impact factor: 3.714

3.  Oral galactose in children with focal and segmental glomerulosclerosis: a novel adjunct therapy.

Authors:  Om P Mishra; Arun K Singh; Martin Pohl; Brijesh Kumar; Vineeta V Batra; Gopeshwar Narayan
Journal:  Clin Kidney J       Date:  2014-02
  3 in total
  2 in total

1.  Response: galactose treatment in focal and segmental glomerulosclerosis.

Authors:  Asha Moudgil; Kristen Sgambat
Journal:  Pediatr Nephrol       Date:  2014-01-18       Impact factor: 3.714

Review 2.  IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome.

Authors:  Agnes Trautmann; Marina Vivarelli; Susan Samuel; Debbie Gipson; Aditi Sinha; Franz Schaefer; Ng Kar Hui; Olivia Boyer; Moin A Saleem; Luciana Feltran; Janina Müller-Deile; Jan Ulrich Becker; Francisco Cano; Hong Xu; Yam Ngo Lim; William Smoyer; Ifeoma Anochie; Koichi Nakanishi; Elisabeth Hodson; Dieter Haffner
Journal:  Pediatr Nephrol       Date:  2020-05-07       Impact factor: 3.714
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.